+

PE20080613A1 - Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos - Google Patents

Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos

Info

Publication number
PE20080613A1
PE20080613A1 PE2007001146A PE2007001146A PE20080613A1 PE 20080613 A1 PE20080613 A1 PE 20080613A1 PE 2007001146 A PE2007001146 A PE 2007001146A PE 2007001146 A PE2007001146 A PE 2007001146A PE 20080613 A1 PE20080613 A1 PE 20080613A1
Authority
PE
Peru
Prior art keywords
phenyl
alkyl
iloxi
halo
urea
Prior art date
Application number
PE2007001146A
Other languages
English (en)
Inventor
Liguo Chi
Chulho Choi
Andrew George Geyer
Robert Michael Kennedy
Jeffrey Allen Pfefferkorn
Roy Thomas Winters
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20080613A1 publication Critical patent/PE20080613A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE X1, X2, X3, X4, X5, X6, X7 SON CADA UNO CH, N CON LA CONDICION QUE NO MAS DE 2 DE X1, X2, X3, X4 SEAN N AL MISMO TIEMPO; Y ES OXI, TIO; R1, R2, R3, R4, R5 Y R6 SON CADA UNO H, ALQUILO C1-C6, HALO, CF2CF3, ENTRE OTROS; R7 ES H, ALQUILO C1-C4, HALO, -CF3; -(CR10R11)n-CO2R12; R10 Y R11 SON CADA UNO H, ALQUILO C1-C4 O HALO; R12 ES H O ALQUILO C1-C6; R8 Y R9 SON CADA UNO H, ALQUILO C1-C6, HIDROXI, -SR13, ENTRE OTROS; R13 ES H, ALQUILO C1-C6. SON COMPUESTOS PREFERIDOS: 1-[2-(5-METIL-2-O-TOLIL-2H-PIRAZOL-3-ILOXI)-FENIL]-3-(4-TRIFLUOROMETOXI-FENIL)-UREA; 1-{2-[2-(2-CLORO-FENIL)-5-METIL-2H-PIRAZOL-3-ILOXI]-FENIL}-3-(4-TRIFLUOROMETOXI-FENIL)-UREA; 1-(4-TERC-BUTIL-FENIL)-3-[2-(5-METIL-2-FENIL-2H-PIRAZOL-3-ILOXI)-PIRIDIN-3-IL]-UREA; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICON FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ANTAGONISTAS DE P2Y UTILES EN TRANSTORNOS TROMBOEMBOLICOS, TRATAMIENTO DE LA INFLAMACION Y AGENTE AUXILIAR DE DIAGNOSTICO
PE2007001146A 2006-08-25 2007-08-23 Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos PE20080613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82351906P 2006-08-25 2006-08-25

Publications (1)

Publication Number Publication Date
PE20080613A1 true PE20080613A1 (es) 2008-05-17

Family

ID=38698411

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001146A PE20080613A1 (es) 2006-08-25 2007-08-23 Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos

Country Status (7)

Country Link
US (1) US20080269293A1 (es)
AR (1) AR062499A1 (es)
CL (1) CL2007002479A1 (es)
PE (1) PE20080613A1 (es)
TW (1) TW200817387A (es)
UY (1) UY30558A1 (es)
WO (1) WO2008023235A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790916B2 (en) * 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
NZ700332A (en) 2010-03-30 2017-06-30 Verseon Corp Multisubstituted aromatic compounds as inhibitors of thrombin
WO2014089364A1 (en) 2012-12-06 2014-06-12 Quanticel Pharmaceuticals, Inc Histone demethylase inhibitors
CN110179795A (zh) 2013-03-15 2019-08-30 维颂公司 作为丝氨酸蛋白酶抑制剂的多取代芳族化合物的制药用途
SG11201506757TA (en) * 2013-03-15 2015-09-29 Verseon Corp Halogenopyrazoles as inhibitors of thrombin
CA2960790A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
BR112017018092A2 (pt) 2015-02-27 2018-04-10 Verseon Corp composto, composição farmacêutica, e, método para tratar e/ou prevenir uma doença ou distúrbio.
CN105037342B (zh) * 2015-08-07 2018-10-09 华中农业大学 具有除草活性的吡唑醚类化合物及其应用
DE102018121508A1 (de) 2018-09-04 2020-03-05 Schunk Ingenieurkeramik Gmbh Tribologischer Körper und Verfahren zum Herstellen eines solchen
EP3990445A4 (en) 2019-06-25 2023-07-05 InventisBio Co., Ltd. HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARATION AND THEIR METHODS OF USE
EP4094762A1 (en) 2021-05-25 2022-11-30 UCL Business Ltd Treatment of neurological indications
EP4095134A1 (en) 2021-05-25 2022-11-30 UCL Business Ltd Polycyclic compounds for the treatment of neurological indications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
MXPA06013022A (es) * 2004-05-12 2007-01-23 Squibb Bristol Myers Co Antagonistas de urea de receptor p2y1 utiles en el tratamiento de condiciones tromboticas.

Also Published As

Publication number Publication date
UY30558A1 (es) 2008-03-31
TW200817387A (en) 2008-04-16
US20080269293A1 (en) 2008-10-30
WO2008023235A1 (en) 2008-02-28
AR062499A1 (es) 2008-11-12
CL2007002479A1 (es) 2008-02-29

Similar Documents

Publication Publication Date Title
PE20080613A1 (es) Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos
PA8591701A1 (es) Derivados de pirrolopirimidina
BRPI0515482A (pt) derivados heterocìclicos e seus usos como agentes terapêuticos
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
UY27368A1 (es) Nuevos compuestos
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20070138A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
AR038476A1 (es) Derivados de quinazolina
AR033525A1 (es) Arilmetilaminas sustituidas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20062677L (no) Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
SE0200979D0 (sv) New compounds
NO20062704L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
PE20071136A1 (es) Derivados de anilina sustituida como antagonistas de la histamina h3
NO20044826L (no) Pyrrolidinderivater
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
PA8586501A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
PE20021066A1 (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, asi como preparados farmaceuticos que las contienen
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
NO20060383L (no) Substituerte diketopiperaziner og deres anvendelse som oksytocinantagonister
NO20014529D0 (no) Tetrahydropyranderivater og deres anvendelse som terapautiske midler

Legal Events

Date Code Title Description
FC Refusal
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载